Patients and healthcare innovators may be fighting opposite sides of the same locked door. What that reveals about access, incentives, advocacy and the case for patient political power.

Doctors and patients were never opposing teams. They’re the 2 people healthcare was built around. So how did we create a system where both can sit in the same exam room feeling powerless while everyone else apparently has a login?

Fitness expert Fitz Koehler did everything “right” and still got breast cancer. She joins Out of Patients to talk exercise oncology, survivorship, wellness snake oil, and why fitness cannot prevent every diagnosis but can help prepare the body for what comes next.

After 30 years in patient advocacy, I seem to have wandered into healthcare policy. A conversation with Chuck Melendi about insurance, incentives, political power, and what happens when patients stop merely navigating the system and start organizing to change it.

Rebecca Bloom spent decades inside employee benefits law before helping women navigate cancer, insurance, disability, work, and survival. This conversation exposes the hidden administrative labor patients inherit the second they get sick.

Women delay care while healthcare systems optimize around assumptions that no longer reflect how people live. Former healthcare investment banker Vasanta Pundarika explains how caregiving, behavioral health, women’s health, and capital incentives collide inside American healthcare.

Cancer patients increasingly rely on AI and patient networks to navigate a healthcare system built around fragmentation and administrative burden. Brad Power explains why patients now trust technology more than the institutions designed to care for them

Dr. Jessica Peatross spent years inside hospital medicine before realizing many chronically ill patients improved only after leaving the system behind. In this episode, she unpacks mold exposure, overmedication, functional medicine, and why patients keep losing trust in healthcare.

Retail executive and breast cancer survivor Farla Efros approached cancer the same way she rescued struggling companies: with strategy, discipline, and relentless preparation. She explains why patients are forced to become CEOs of their own care and why the system rewards those who can.

Long COVID did not create a crisis. It exposed one. Patients without clear diagnoses lose access to care, coverage, and credibility. When medicine cannot measure your illness, the system moves on. Here is what that looks like and who pays the price

US healthcare does not fail when it denies care. It performs as designed. This essay involving the life of Jace Yawnick examines how insurance incentives, prior authorization, and employer based coverage shape access, delay treatment, and shift risk onto patients while increasing total cost.

Patients now need executive level skills to survive diagnosis, treatment, and access. This essay featuring Kathy Giusti breaks down how healthcare incentives create that reality, who benefits, who pays, and what must change to reduce risk and restore accountability.

At 19, Shlomit Liberty lost speech and got sent home with “stress.” Now she spends 15 to 20 hours a week guiding families through hospital chaos. This episode exposes how discharge, insurance rules, and system incentives leave patients confused and paying the price.

Conversion therapy persists under new names and softer language. Evidence rejects its claims, yet institutions continue to profit from hope and shame. This essay examines consumer fraud law, religious authority, and the healthcare system’s role in protecting vulnerable patients.

A ruptured brain aneurysm triggered elite emergency care that saved a life. Insurance policy still blocks preventive screening for her child. This piece explains how US healthcare pays for catastrophe and delays detection, and what must change before the next bleed.

Dr. Hesham Hassaballa is board certified four times over with 20 years in the ICU. When his daughter was getting chemo, he checked his insurance portal daily, terrified they would drop her. A physician. In the system. Earning a good living. Still terrified of financial ruin because his child got sick.

Matthew Zachary joins Humanity Rx to break down how modern cancer care improves survival while leaving patients exposed to medical debt, prior authorization delays, and financial risk, and why policy change depends on organized patient power.

Women were excluded from U.S. clinical trials until 1993. That decision shaped drug safety, outcomes, and cost for decades. This essay breaks down the incentives, capital flows, and regulatory gaps that sustained it and what must change next.

Monique Gore Massy spent 2.5 years misdiagnosed while lupus shut her body down. This episode exposes bias, diagnostic delay, and the cost of dismissing patients who “look fine,” and what happens when lived experience demands real authority.